Ropharma Bras

Ropharma Bras

RPH · RO · Healthcare / Pharmaceutical Retailers

0.24RON-0.00 (-0.83%)

Price History

Full chart

Market Stats

Previous Close0.242
Open0.246
Day Range0.236 – 0.246
52-Week Range0.15 – 0.228
Volume35.65K
Market Cap108.39M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.33
50-Day Avg0.2175
200-Day Avg0.2057

About

S.C. Ropharma S.A., together with its subsidiaries, operates a chain of pharmacies in Romania. The company offers medicines on prescription, over-the-counter (OTC) medications, food supplements, dermato-cosmetics, cosmetics, and medical devices, as well as other healthcare products dispensed through pharmacies. It also provides medical services in various areas, including oncology, hematology, oncological surgery and HIPEC, bariatric surgery, thoracic surgery, and robotic surgery; and operates renal transplant and cardiovascular disease center. In addition, the company offers products with lactoferrin, vitamins and minerals in tablets/sachets, plant extracts, pre and probiotics, product with natural enzyme, and cosmetics. Further, it is involved in retail and distribution of pharmaceutical products; production of pharmaceutical products, food supplements, and dermocosmetics; and provision of medical ang hospital services. The company was incorporated in 1952 and is headquartered in Brasov, Romania.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEODr. Mihai Miron
  • Employees1.26K
  • HeadquartersStr. luliu Maniu no. 55, Brasov, Romania, Romania
  • Websitehttps://www.ropharma.ro

Leadership

  • Dr. Mihai MironChairman, GM, CEO & Director General · b. 1960
  • Dr. Alin Constantin RadasanuCFO & Member of the Board of Directors · b. 1972
  • Engineer Danut Marian EneHR Director & Member of Board of Directors · b. 1968

Financials

Income Statement

Currency: RON2021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue717.81M776.69M912.74M1.01B1.19B
Growth (%)-+8.20%+17.52%+10.26%+18.35%
Cost of Revenue621.77M682.78M783.09M861.88M1.03B
Gross Profit96.03M93.91M129.65M144.48M165.89M
Gross Margin13.38%12.09%14.20%14.36%13.93%
Operating Expense81.48M75.79M119.99M126.37M138.13M
Operating Income14.56M18.11M9.66M18.11M27.76M
Operating Margin2.03%2.33%1.06%1.80%2.33%
EBITDA-39.89M37.55M45.90M56.05M
EBITDA Margin-5.14%4.11%4.56%4.71%
Net Income6.75M10.73M9.22M7.72M-1.73M
Net Income Margin0.94%1.38%1.01%0.77%-0.14%
Interest Expense3.26M3.21M3.44M5.56M5.86M
Interest Expense % of Total Revenue0.45%0.41%0.38%0.55%0.49%

Balance Sheet

Currency: RON2020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets-430.53M427.32M770.25M807.78M947.76M
Total Liabilities-255.62M242.40M536.76M555.92M688.42M
Total Equity-174.90M184.92M231.59M240.08M245.23M
Cash-8.60M5.21M15.42M16.51M19.90M
Net Debt-43.92M41.43M61.81M53.92M47.87M

Cash Flow

Currency: RON2013-06-302014-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow----8.64M14.65M29.94M40.49M43.16M
Capital Expenditure00015.91M34.47M18.06M16.16M18.74M
Free Cash Flow----24.55M-19.82M11.88M24.33M24.42M
Dividends Paid-----1.49M2.55M4.23M
FCF to OCF---284.19%-135.23%39.67%60.09%56.58%
Dividend Paid to FCF-----12.53%10.48%17.32%

Earnings

Report DateNov 14, 2014Aug 4, 2016Mar 1, 2017Aug 30, 2017Feb 28, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Mar 2, 2022Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023May 31, 2023
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.020.010.010.000.010.000.020.000.000.000.010.000.000.000.010.000.010.000.020.000.010.000.000.00
Surprise--------------------------
Timing--------------------------

Key Statistics & Ratios

Market Cap108.39M
Enterprise Value248.86M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.07
Price / Book0.43
EPS0.00
Book Value0.502
Revenue (TTM)1.67B
Gross Profit (TTM)330.41M
EBITDA34.67M
Profit Margin0.49%
Operating Margin0.29%
Return on Equity3.71%
Return on Assets1.27%
Shares Outstanding511.27M
Shares Float128.47M
Beta0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 3, 20131.75:1